CycloSam Therapeutics Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $200K
Latest Deal Amount

CycloSam Therapeutics General Information


Developer of a bone seeking agent created to treat metastatic bone cancer. The company's bone seeking agent allows delivery of high amounts of radioactivity to bone and bone tumors while reducing bone marrow suppression, enabling treatment of osteosarcoma and relief of pain from bone metastases as well as reduced myelotoxicity for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Primary Office
  • 1004 South Velasco Street
  • Angleton, TX 77515
  • United States
+1 (979) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CycloSam Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 27-Jan-2017 $200K 00000 Completed Startup
To view CycloSam Therapeutics’s complete valuation and funding history, request access »

CycloSam Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
R. Frank Ph.D President & Board Member
You’re viewing 1 of 2 executive team members. Get the full list »

CycloSam Therapeutics Board Members (4)

Name Representing Role Since
Joseph Rybak CycloSam Therapeutics Board Member 000 0000
R. Frank Ph.D CycloSam Therapeutics President & Board Member 000 0000
Stephen Ellebracht CycloSam Therapeutics Board Member 000 0000
You’re viewing 3 of 4 board members. Get the full list »